Orzaks Ilac Ve Kimya Sanayi Ticaret Anonim Sirketi (IST:ORZAX)
Turkey · Delayed Price · Currency is TRY 86.45
+0.95 (1.11%)
At close: Sep 11, 2026
IST:ORZAX Income Statement
Financials in millions TRY. Fiscal year is January - December.
Millions TRY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| 8,532 | 7,331 | 5,715 | 7,618 | |
Revenue Growth | - | 28.29% | -24.98% | - |
Cost of Revenue | 2,899 | 2,588 | 2,007 | 4,062 |
Gross Profit | 5,633 | 4,743 | 3,707 | 3,556 |
Selling, General & Admin | 2,964 | 2,388 | 1,713 | 1,392 |
Other Operating Expenses | -40.63 | -155.37 | -89.12 | 29.51 |
Operating Expenses | 2,924 | 2,233 | 1,624 | 1,422 |
Operating Income | 2,709 | 2,511 | 2,083 | 2,134 |
Interest Expense | -1,470 | -930.76 | -689.71 | -397.37 |
Interest & Investment Income | 813.36 | 620.07 | 403.84 | 418.57 |
Currency Exchange Gain (Loss) | 25.27 | -31.95 | -21.75 | -77.41 |
Other Non Operating Income (Expenses) | -468.27 | -606.26 | -757.11 | -765.25 |
EBT Excluding Unusual Items | 1,610 | 1,562 | 1,018 | 1,313 |
Gain (Loss) on Sale of Investments | -1.65 | -1.53 | -1.76 | -0.38 |
Legal Settlements | -0.31 | -1.45 | -3.76 | -2.64 |
Pretax Income | 1,608 | 1,559 | 1,013 | 1,310 |
Income Tax Expense | 450.09 | 505.87 | 287.43 | 402.56 |
Earnings From Continuing Operations | 1,158 | 1,053 | 725.25 | 907.27 |
Minority Interest in Earnings | - | - | - | 59.13 |
Net Income | 1,158 | 1,053 | 725.25 | 966.41 |
Net Income to Common | 1,158 | 1,053 | 725.25 | 966.41 |
Net Income Growth | - | 45.16% | -24.95% | - |
Shares Outstanding (Basic) | 307 | 307 | 307 | 71 |
Shares Outstanding (Diluted) | 307 | 307 | 307 | 71 |
Shares Change | - | - | 333.21% | - |
EPS (Basic) | 3.77 | 3.43 | 2.36 | 13.64 |
EPS (Diluted) | 3.77 | 3.43 | 2.36 | 13.64 |
EPS Growth | - | 45.16% | -82.68% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Free Cash Flow | -945.8 | -1,202 | 392.84 | 1,232 |
Free Cash Flow Per Share | -3.08 | -3.92 | 1.28 | 17.38 |
Gross Margin | 66.02% | 64.70% | 64.87% | 46.68% |
Operating Margin | 31.75% | 34.24% | 36.45% | 28.02% |
Profit Margin | 13.57% | 14.36% | 12.69% | 12.69% |
Free Cash Flow Margin | -11.09% | -16.40% | 6.87% | 16.17% |
EBITDA | 2,913 | 2,703 | 2,247 | 2,355 |
EBITDA Margin | 34.14% | 36.86% | 39.32% | 30.92% |
D&A For EBITDA | 203.33 | 192.13 | 164.25 | 221.08 |
EBIT | 2,709 | 2,511 | 2,083 | 2,134 |
EBIT Margin | 31.75% | 34.24% | 36.45% | 28.02% |
Effective Tax Rate | 28.00% | 32.45% | 28.38% | 30.73% |